Zhiqian Wang
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
LncRNA TAF1A-AS1 regulates the progression in hepatocellular carcinoma by targeting miR-664b-3p/USP22 axis.
Journal: Discover oncology
Published: September 26, 2025
Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 02, 2023
The m6A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway.
Journal: Molecular cancer
Published: June 15, 2022
Long Non-Coding RNA LINC01572 Promotes Hepatocellular Carcinoma Progression via Sponging miR-195-5p to Enhance PFKFB4-Mediated Glycolysis and PI3K/AKT Activation.
Journal: Frontiers in cell and developmental biology
Published: September 25, 2021
LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 25, 2021
LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 30, 2020
cPLA2a correlates with metastasis and poor prognosis of osteosarcoma by facilitating epithelial-mesenchymal transition.
Journal: Pathology, research and practice
Published: January 28, 2019
FOXN3 is downregulated in osteosarcoma and transcriptionally regulates SIRT6, and suppresses migration and invasion in osteosarcoma.
Journal: Oncology reports
Published: January 18, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026